Insights

Expanding Patient Access Novartis is launching a direct-to-patient platform in the US offering significant discounts on prescribed medications like Cosentyx, indicating an opportunity to engage with healthcare providers and pharmacies to facilitate wider medication distribution and patient engagement strategies.

Innovative Research Pipeline With over 50 ongoing Phase III clinical programs and new data presentations at major industry events, Novartis demonstrates a commitment to cutting-edge treatments, providing opportunities to position ancillary services or complementary products aligned with their product development focus.

Diverse Market Engagement Active participation in global events such as the World Economic Forum and specialized conferences suggests Novartis values strategic networking, presenting prospects to offer tailored solutions in healthcare policy, digital health, or sustainability initiatives targeting their leadership.

Technology Adoption Novartis utilizes a range of advanced tech platforms including Veeva Systems CRM and Splunk Enterprise Security, indicating potential for offering complementary digital transformation services, security solutions, or innovative data analytics tools to streamline their operations.

Focus on Sustainability and Efficiency Recognition for innovations like stability prediction tools and automated production systems highlights their interest in sustainable and efficient manufacturing, creating opportunities to introduce environmentally-friendly technologies and process optimization solutions.

Novartis, Australia & New Zealand Tech Stack

Novartis, Australia & New Zealand uses 8 technology products and services including QuickBooks, Adobe Illustrator, SCADA, and more. Explore Novartis, Australia & New Zealand's tech stack below.

  • QuickBooks
    Accounting And Finance
  • Adobe Illustrator
    Cad & Graphics
  • SCADA
    Control Systems
  • Calabrio
    Customer Experience Management
  • Argo Project
    Data Management Platforms
  • Digital Product Delivery
    E-commerce Platforms
  • Android
    Programming Languages
  • GraphPad Prism
    Visualisation Software

Media & News

Novartis, Australia & New Zealand's Email Address Formats

Novartis, Australia & New Zealand uses at least 1 format(s):
Novartis, Australia & New Zealand Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

Where is Novartis, Australia & New Zealand's headquarters located?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's main headquarters is located at 54 Waterloo Road, Macquarie Park, NSW 2113, AU. The company has employees across 6 continents, including OceaniaAsiaNorth America.

What is Novartis, Australia & New Zealand's phone number?

Minus sign iconPlus sign icon
You can contact Novartis, Australia & New Zealand's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novartis, Australia & New Zealand's official website and social media links?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis, Australia & New Zealand's NAICS code?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis, Australia & New Zealand have currently?

Minus sign iconPlus sign icon
As of October 2025, Novartis, Australia & New Zealand has approximately 501 employees across 6 continents, including OceaniaAsiaNorth America. Key team members include Chief Scientific Officer: D. V. V.Head Of Customer Experience And Omnichannel: A. L.Head Of Trade: D. T.. Explore Novartis, Australia & New Zealand's employee directory with LeadIQ.

What industry does Novartis, Australia & New Zealand belong to?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis, Australia & New Zealand use?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's tech stack includes QuickBooksAdobe IllustratorSCADACalabrioArgo ProjectDigital Product DeliveryAndroidGraphPad Prism.

What is Novartis, Australia & New Zealand's email format?

Minus sign iconPlus sign icon
Novartis, Australia & New Zealand's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis, Australia & New Zealand email formats with LeadIQ.

How much funding has Novartis, Australia & New Zealand raised to date?

Minus sign iconPlus sign icon
As of October 2025, Novartis, Australia & New Zealand has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.
Novartis, Australia & New Zealand

Novartis, Australia & New Zealand

Pharmaceutical ManufacturingAustralia501-1000 Employees

Novartis is improving the lives of more than 2.5 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.
 
We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich research pipeline has 50+ ongoing Phase III programs. We are transforming how clinical trials are run to increase patients’ access to our industry-leading clinical trials footprint in Australia.
 
We continue to work on improving our environment for diversity, equity and inclusion and being a family friendly employer. Every day our inspired, curious, unbossed, and integrity-driven culture unites our people and encourages leadership at every level.  

See our community guidelines here: https://bit.ly/2meXCdH

Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money. All our current job openings are displayed here and on our novartis.com.au website.

If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.

Section iconCompany Overview

Headquarters
54 Waterloo Road, Macquarie Park, NSW 2113, AU
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $2.4B

    Novartis, Australia & New Zealand has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $25M$50M

    Novartis, Australia & New Zealand's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $2.4B

    Novartis, Australia & New Zealand has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $25M$50M

    Novartis, Australia & New Zealand's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.